PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Cellebrite DI Ltd. (CLBT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINIL0011794802
CUSIP90117G105
SectorTechnology
IndustrySoftware—Infrastructure

Highlights

Market Cap$2.23B
EPS-$0.43
PE Ratio70.00
Revenue (TTM)$311.55M
Gross Profit (TTM)$219.91M
EBITDA (TTM)$43.95M
Year Range$5.22 - $12.50
Target Price$13.58
Short %2.53%
Short Ratio2.42

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cellebrite DI Ltd.

Popular comparisons: CLBT vs. CRT, CLBT vs. VOO, CLBT vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cellebrite DI Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%December2024FebruaryMarchAprilMay
11.28%
43.00%
CLBT (Cellebrite DI Ltd.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Cellebrite DI Ltd. had a return of 24.13% year-to-date (YTD) and 99.44% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date24.13%5.21%
1 month-2.36%-4.30%
6 months56.93%18.42%
1 year99.44%21.82%
5 years (annualized)N/A11.27%
10 years (annualized)N/A10.33%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.39%32.41%-7.44%-2.44%
2023-12.68%26.50%2.49%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of CLBT is 93, placing it in the top 7% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of CLBT is 9393
Cellebrite DI Ltd.(CLBT)
The Sharpe Ratio Rank of CLBT is 9696Sharpe Ratio Rank
The Sortino Ratio Rank of CLBT is 9494Sortino Ratio Rank
The Omega Ratio Rank of CLBT is 9292Omega Ratio Rank
The Calmar Ratio Rank of CLBT is 9090Calmar Ratio Rank
The Martin Ratio Rank of CLBT is 9595Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cellebrite DI Ltd. (CLBT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CLBT
Sharpe ratio
The chart of Sharpe ratio for CLBT, currently valued at 2.54, compared to the broader market-2.00-1.000.001.002.003.004.002.54
Sortino ratio
The chart of Sortino ratio for CLBT, currently valued at 3.38, compared to the broader market-4.00-2.000.002.004.006.003.38
Omega ratio
The chart of Omega ratio for CLBT, currently valued at 1.42, compared to the broader market0.501.001.501.42
Calmar ratio
The chart of Calmar ratio for CLBT, currently valued at 1.72, compared to the broader market0.002.004.006.001.72
Martin ratio
The chart of Martin ratio for CLBT, currently valued at 13.76, compared to the broader market-10.000.0010.0020.0030.0013.76
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.74, compared to the broader market-2.00-1.000.001.002.003.004.001.74
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.53, compared to the broader market-4.00-2.000.002.004.006.002.53
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.30, compared to the broader market0.501.001.501.30
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.002.004.006.001.33
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.79, compared to the broader market-10.000.0010.0020.0030.006.79

Sharpe Ratio

The current Cellebrite DI Ltd. Sharpe ratio is 2.54. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Cellebrite DI Ltd. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00December2024FebruaryMarchAprilMay
2.54
1.74
CLBT (Cellebrite DI Ltd.)
Benchmark (^GSPC)

Dividends

Dividend History


Cellebrite DI Ltd. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-12.53%
-4.49%
CLBT (Cellebrite DI Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cellebrite DI Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cellebrite DI Ltd. was 67.74%, occurring on Sep 30, 2022. Recovery took 355 trading sessions.

The current Cellebrite DI Ltd. drawdown is 12.53%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-67.74%Sep 17, 2021262Sep 30, 2022355Mar 1, 2024617
-15.54%Mar 4, 202432Apr 17, 2024
-14.66%Feb 19, 2021141Sep 9, 20215Sep 16, 2021146
-4.55%Jan 25, 20213Jan 27, 20219Feb 9, 202112
-3.87%Jan 14, 20212Jan 15, 20212Jan 20, 20214

Volatility

Volatility Chart

The current Cellebrite DI Ltd. volatility is 8.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2024FebruaryMarchAprilMay
8.16%
3.91%
CLBT (Cellebrite DI Ltd.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cellebrite DI Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items